These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 38623660)
1. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants. Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660 [TBL] [Abstract][Full Text] [Related]
2. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines. So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392 [TBL] [Abstract][Full Text] [Related]
3. Reclassification of Ha HI; Ryu JS; Shim H; Kong SY; Lim MC J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592 [TBL] [Abstract][Full Text] [Related]
4. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study. Kim JH; Park S; Park HS; Park JS; Lee ST; Kim SW; Lee JW; Lee MH; Park SK; Noh WC; Choi DH; Han W; Jung SH Sci Rep; 2021 Apr; 11(1):8485. PubMed ID: 33875706 [TBL] [Abstract][Full Text] [Related]
5. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population. Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972 [TBL] [Abstract][Full Text] [Related]
6. Reclassification of Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210 [TBL] [Abstract][Full Text] [Related]
7. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families. Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278 [TBL] [Abstract][Full Text] [Related]
8. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots". Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil. Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148 [TBL] [Abstract][Full Text] [Related]
10. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from "Uncertain Significance" to "Pathogenic" based on minigene assays and clinical evidence. Ning Y; Zhang Y; Tian T; Chen Y; Wang J; Lei K; Cui Z J Cancer Res Clin Oncol; 2024 Feb; 150(2):62. PubMed ID: 38300310 [TBL] [Abstract][Full Text] [Related]
11. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance. Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C Gene; 2023 Apr; 862():147281. PubMed ID: 36775216 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants. Park KS; Cho EY; Nam SJ; Ki CS; Kim JW Genet Med; 2016 Dec; 18(12):1250-1257. PubMed ID: 27124784 [TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB; Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499 [TBL] [Abstract][Full Text] [Related]
14. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes. Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations]. Duan RR; Sun LX; Zhao HW Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292 [No Abstract] [Full Text] [Related]
16. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants. Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081 [TBL] [Abstract][Full Text] [Related]
17. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey. Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318 [TBL] [Abstract][Full Text] [Related]
19. Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants. Cline MS; Babbi G; Bonache S; Cao Y; Casadio R; de la Cruz X; Díez O; Gutiérrez-Enríquez S; Katsonis P; Lai C; Lichtarge O; Martelli PL; Mishne G; Moles-Fernández A; Montalban G; Mooney SD; O'Conner R; Ootes L; Özkan S; Padilla N; Pagel KA; Pejaver V; Radivojac P; Riera C; Savojardo C; Shen Y; Sun Y; Topper S; Parsons MT; Spurdle AB; Goldgar DE; Hum Mutat; 2019 Sep; 40(9):1546-1556. PubMed ID: 31294896 [TBL] [Abstract][Full Text] [Related]
20. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]